Univariate analysis | Multivariate analysis | |||
OR (95% CI) | P value | OR (95% CI) | P value | |
Age | 1.01 (0.99 to 1.03) | 0.18 | 1.01 (0.99 to 1.03) | 0.37 |
NT-proBNP | 2.44 (1.37 to 4.35) | 0.002 | 0.88 (0.45 to 1.72) | 0.71 |
cTNI-ultra | 0.88 (0.53 to 1.49) | 0.64 | ||
LVEF | 0.99 (0.95 to 1.02) | 0.35 | ||
Paroxysmal AF | 4.04 (2.00 to 8.14) | <0.001 | 1.43 (0.65 to 3.18) | 0.37 |
Persistent AF | 5.93 (3.36 to 10.46) | <0.001 | 2.36 (1.22 to 4.55) | 0.011 |
Ischaemic heart disease | 3.02 (1.88 to 4.86) | <0.001 | 2.40 (1.43 to 3.99) | 0.001 |
Malignancy | 2.82 (1.71 to 4.67) | <0.001 | 2.77 (1.57 to 4.87) | <0.001 |
Septicaemia | 1.45 (0.75 to 2.81) | 0.27 | ||
COPD | 1.48 (0.74 to 2.95) | 0.27 | ||
Pulmonary artery hypertension | 1.50 (0.80 to 2.84) | 0.21 | ||
History of VTE | 0.70 (0.42 to 1.15) | 0.16 | ||
Cerebral infarction | 2.22 (1.34 to 3.67) | 0.002 | 1.93 (1.09 to 3.40) | 0.023 |
Diabetes | 1.38 (0.56 to 3.41) | 0.49 | ||
Pulmonary infection | 1.36 (0.87 to 2.12) | 0.18 | ||
Chronic cor pulmonale | 1.90 (0.83 to 4.35) | 0.13 | ||
Congestive heart failure | 4.06 (2.64 to 6.24) | <0.001 | 2.50 (1.51 to 4.12) | <0.001 |
Massive PE | 3.50 (1.98 to 6.19) | <0.001 | 2.76 (1.51 to 5.03) | 0.001 |
Submassive PE | 0.69 (0.38 to 1.27) | 0.24 | 0.68 (0.36 to 1.29) | 0.24 |
cTnI-ultra; cardiac troponin I ultra; AF, atrial fibrillation; COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; NT-proBNP, amino-terminal pro-brain natriuretic peptide; PE, pulmonary embolism; VTE, venous thromboembolism.